Literature DB >> 21049463

Genetic predisposition to papillary thyroid cancer.

Dorota Kula1, Michał Kalemba, Beata Jurecka-Lubieniecka, Zbigniew Puch, Małgorzata Kowalska, Tomasz Tyszkiewicz, Monika Kowal, Daria Handkiewicz-Junak.   

Abstract

Approximately 5% of differentiated thyroid cancers are hereditary. Hereditary non-medullary thyroid cancer may occur as a minor component of familial cancer syndromes (e.g. familial adenomatous polyposis) or as a primary feature (familial non-medullary thyroid cancer [FNMTC]). Among FNMTC, PTC is the most common. Although a hereditary predisposition to non-medullary thyroid cancer is well established, the susceptibility genes are poorly known. Up to now, by linkage analysis using microsatellite markers, several putative loci have been described - 1q21, 6q22, 8p23.1-p22, and 8q24; however, validation studies have been unsuccessful. In the present review we discuss the results of linkage analysis and the most recent results of genome wide association studies (GWAS) with high resolution SNP (single nucleotide polymorphism) arrays.

Entities:  

Mesh:

Year:  2010        PMID: 21049463

Source DB:  PubMed          Journal:  Endokrynol Pol        ISSN: 0423-104X            Impact factor:   1.582


  3 in total

1.  Increasing incidence of thyroid cancer in Great Britain, 1976-2005: age-period-cohort analysis.

Authors:  Richard J Q McNally; Karen Blakey; Peter W James; Basilio Gomez Pozo; Nermine O Basta; Juliet Hale
Journal:  Eur J Epidemiol       Date:  2012-07-04       Impact factor: 8.082

2.  The investigation of foxe1 variations in papillary thyroid carcinoma.

Authors:  Erkan Somuncu; Adem Karatas; Sina Ferahman; Neslihan Saygili; Eren Yilmaz; Oguz Ozturk; Metin Kapan
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  Network-Based Analysis Reveals Association of FOXE1 Gene Polymorphisms in Thyroid Cancer Patients; A Case-Control Study in Southeast of Iran.

Authors:  Ahmad Mehrazin; Hossein Safarpour; Seyedeh Tahmineh Davoudi; Negin Parsamanesh; Farhad Saeedi; Ebrahim Miri-Moghaddam
Journal:  Asian Pac J Cancer Prev       Date:  2020-09-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.